Education
About Us
Working with TipRanks
Follow Us
Aroa Biosurgery Ltd (AU:ARX)
ASX:ARX
ARX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.35 - AU$0.82
Previous CloseN/A
Volume195.72K
Average Volume (3M)304.13K
Market Cap
AU$179.35M
Enterprise ValueN/A
Total Cash (Recent Filing)AU$20.12M
Total Debt (Recent Filing)AU$6.32M
Price to Earnings (P/E)―
Beta0.50
Next Earnings
May 29, 2025EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding344,900,270
10 Day Avg. Volume489,499
30 Day Avg. Volume304,125
Financial Highlights & Ratios
PEG Ratio-0.59
Price to Book (P/B)1.87
Price to Sales (P/S)0.00
P/FCF Ratio-21.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.82Price Target Upside57.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Aroa Biosurgery Ltd News
PremiumCompany Announcements
Aroa Biosurgery Transitions to New Share Registry Provider
PremiumCompany Announcements
Aroa Biosurgery Reports Strong FY25 Results and Positive Outlook for FY26PremiumCompany Announcements
Aroa Biosurgery Updates Full Year 2025 Financial Results Webinar Date
PremiumCompany Announcements
Australian Ethical Investment Becomes Substantial Holder in Aroa Biosurgery
PremiumCompany Announcements
Aroa Biosurgery Ltd: Advancing Regenerative Healing in Q4 FY’25
PremiumCompany Announcements
Aroa Biosurgery to Host Webinar on Quarterly ResultsOptions Prices
Currently, No data available
---
Ownership Overview
0.17% Insiders
0.05%
Mutual Funds
― Other Institutional Investors
99.78% Public Companies and
Individual Investors
ARX FAQ
What was Aroa Biosurgery Ltd’s price range in the past 12 months?
Aroa Biosurgery Ltd lowest share price was AU$0.35 and its highest was AU$0.81 in the past 12 months.
What is Aroa Biosurgery Ltd’s market cap?
Aroa Biosurgery Ltd’s market cap is AU$179.35M.
When is Aroa Biosurgery Ltd’s upcoming earnings report date?
Aroa Biosurgery Ltd’s upcoming earnings report date is May 29, 2025 which is 12 days ago.
How were Aroa Biosurgery Ltd’s earnings last quarter?
Aroa Biosurgery Ltd released its earnings results on Nov 25, 2024. The company reported -AU$0.009 earnings per share for the quarter, missing the consensus estimate of -AU$0.006 by -AU$0.003.
Is Aroa Biosurgery Ltd overvalued?
According to Wall Street analysts Aroa Biosurgery Ltd’s price is currently Undervalued.
Does Aroa Biosurgery Ltd pay dividends?
Aroa Biosurgery Ltd does not currently pay dividends.
What is Aroa Biosurgery Ltd’s EPS estimate?
Aroa Biosurgery Ltd’s EPS estimate is <0.01.
How many shares outstanding does Aroa Biosurgery Ltd have?
Aroa Biosurgery Ltd has 344,900,270 shares outstanding.
What happened to Aroa Biosurgery Ltd’s price movement after its last earnings report?
Aroa Biosurgery Ltd reported an EPS of -AU$0.009 in its last earnings report, missing expectations of -AU$0.006. Following the earnings report the stock price went up 12.766%.
Which hedge fund is a major shareholder of Aroa Biosurgery Ltd?
Currently, no hedge funds are holding shares in AU:ARX
Aroa Biosurgery Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$0.82 (57.69% Upside)
AU$0.82 (57.69% Upside)
Blogger Sentiment
Bullish
AU:ARX Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.77%
12-Months-Change
Fundamentals
Return on Equity
-4.06%
Trailing 12-Months
Asset Growth
-2.82%
Trailing 12-Months
Company Description
Aroa Biosurgery Ltd
Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and distributing medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. The company's products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction. Aroa Biosurgery Limited was incorporated in 2007 and is headquartered in Auckland, New Zealand.
ARX Stock 12 Month Forecast
Average Price Target
AU$0.82
▲(57.69%Upside)
Technical Analysis
Cochlear
―
CSL
―
Fisher & Paykel Healthcare Corporation Limited
―
Nanosonics Limited
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―